151 related articles for article (PubMed ID: 35659782)
1. In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication.
Favi E; Signorini L; Villani S; Dolci M; Ticozzi R; Basile G; Ferrante P; Ferraresso M; Delbue S
Transplant Proc; 2022 Sep; 54(7):2035-2041. PubMed ID: 35659782
[TBL] [Abstract][Full Text] [Related]
2. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.
Hirsch HH; Yakhontova K; Lu M; Manzetti J
Am J Transplant; 2016 Mar; 16(3):821-32. PubMed ID: 26639422
[TBL] [Abstract][Full Text] [Related]
3. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
Jaw J; Hill P; Goodman D
Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
[TBL] [Abstract][Full Text] [Related]
4. Use of Leflunomide as an Antiviral Agent with Everolimus for BK Virus Nephropathy Patients After Kidney Transplantation: A Case Series.
Yamazaki T; Shirai H; Tojimbara T
Am J Case Rep; 2020 Nov; 21():e927367. PubMed ID: 33235184
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
6. The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.
Suwelack B; Malyar V; Koch M; Sester M; Sommerer C
Transplant Rev (Orlando); 2012 Jul; 26(3):201-11. PubMed ID: 21940156
[TBL] [Abstract][Full Text] [Related]
7. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
[TBL] [Abstract][Full Text] [Related]
8. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
9. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
[TBL] [Abstract][Full Text] [Related]
10. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.
Yilmaz VT; Kisaoglu A; Avanaz A; Dandin O; Ozel D; Mutlu D; Akkaya B; Aydinli B; Kocak H
Exp Clin Transplant; 2023 Sep; 21(9):727-734. PubMed ID: 37885288
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies against BK polyomavirus infection in kidney transplant recipients: Systematic review and meta-analysis.
Zhong C; Chen J; Yan Z; Xia R; Zeng W; Deng W; Xu J; Wang Y; Miao Y
Transpl Immunol; 2023 Dec; 81():101953. PubMed ID: 37931665
[TBL] [Abstract][Full Text] [Related]
12. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
Pape L; Tönshoff B; Hirsch HH;
Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
[TBL] [Abstract][Full Text] [Related]
14. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment for BK Virus Nephropathy by Leflunomide in a Kidney Transplant Patient: A Case Report.
Wu MY; Chen YW; Hung LY; Lee CH; Chen HA; Hsu YH; Wu MS
Transplant Proc; 2019 Jun; 51(5):1472-1474. PubMed ID: 31084921
[TBL] [Abstract][Full Text] [Related]
17. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection.
Liacini A; Seamone ME; Muruve DA; Tibbles LA
Transplantation; 2010 Dec; 90(12):1450-7. PubMed ID: 21079551
[TBL] [Abstract][Full Text] [Related]
18. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Hirsch HH; Randhawa PS;
Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
